UBS O'Connor’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-125,589
| Closed | -$965K | – | 345 |
|
|
2024
Q4 | $965K | Buy |
125,589
+59,649
| +90% | +$458K | 0.03% | 225 |
|
|
2024
Q3 | $673K | Buy |
65,940
+30,617
| +87% | +$313K | 0.02% | 315 |
|
|
2024
Q2 | $524K | Buy |
+35,323
| New | +$524K | 0.01% | 355 |
|
|
2023
Q4 | – | Sell |
-59,764
| Closed | -$654K | – | 489 |
|
|
2023
Q3 | $654K | Buy |
59,764
+8,000
| +15% | +$87.6K | 0.01% | 357 |
|
|
2023
Q2 | $685K | Sell |
51,764
-17,536
| -25% | -$232K | 0.01% | 409 |
|
|
2023
Q1 | $943K | Buy |
+69,300
| New | +$943K | 0.02% | 409 |
|
|
2022
Q4 | – | Sell |
-57,500
| Closed | -$1.1M | – | 159 |
|
|
2022
Q3 | $1.1M | Buy |
57,500
+5,000
| +10% | +$95.2K | 0.01% | 725 |
|
|
2022
Q2 | $1.08M | Buy |
+52,500
| New | +$1.08M | 0.01% | 739 |
|